55P - TP53 mutations as predictor of response and longer survival under immune checkpoint inhibitors in advanced non-small cell lung cancer

Bibliographic Details
Title: 55P - TP53 mutations as predictor of response and longer survival under immune checkpoint inhibitors in advanced non-small cell lung cancer
Authors: Assoun, S., Theou-Anton, N., Nguenang, M., Cazes, A., Danel, C., Abbar, B., Pluvy, J., Gounant, V., Khalil, A., Namour, C., Brosseau, S., Zalcman, G.
Source: In Annals of Oncology September 2018 29 Supplement 6:vi19-vi19
Database: ScienceDirect
More Details
ISSN:09237534
DOI:10.1093/annonc/mdy315.005
Published in:Annals of Oncology
Language:English